CINACALCET HYDROCHLORIDE | A206125 | AUROBINDO PHARMA LTD
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
| D. Del. | 2016-09-22 | Terminated 2020-09-08 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
Highest NADAC/Unit
$0.9985
per ea
Lowest NADAC/Unit
$0.4013
per ea
Brand NDCs
0
Generic NDCs
6
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 65862083305CINACALCET HCL 90 MG TABLET | $0.9985 | EA | Generic | — | 2026-06-17 |
| 65862083330CINACALCET HCL 90 MG TABLET | $0.9985 | EA | Generic | — | 2026-06-17 |
| 65862083205CINACALCET HCL 60 MG TABLET | $0.7636 | EA | Generic | — | 2026-06-17 |
| 65862083230CINACALCET HCL 60 MG TABLET | $0.7636 | EA | Generic | — | 2026-06-17 |
| 65862083105CINACALCET HCL 30 MG TABLET | $0.4013 | EA | Generic | — | 2026-06-17 |
| 65862083130CINACALCET HCL 30 MG TABLET | $0.4013 | EA | Generic | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.